Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery

Anesthesia and Analgesia

Volumn 114, Issue 3, 2012, Pages 552-560

  Turan, Alparslan ^a   You, Jing ^a   Shiba, Ayako ^a   Kurz, Andrea ^a   Saager, Leif ^a   Sessler, Daniel I ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACID ASPIRATION; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLEEDING; BRAIN DAMAGE; BRAIN HYPOXIA; BRONCHOSPASM; CARDIOPULMONARY INSUFFICIENCY; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG FATALITY; FEMALE; GENERAL ANESTHESIA; HEART ARREST; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; KIDNEY DISEASE; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OLIGURIA; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PNEUMOTHORAX; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; SHOCK LUNG; STROKE; SURGICAL PATIENT; THROMBOPHLEBITIS; URINARY DIVERSION; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; POSTOPERATIVE COMPLICATIONS; RESPIRATION DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84857647383     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318241f6af     Document Type: Article

References (32)

1. Fox KM, Investigators EUtOrocewPiscAd. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8
2. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein, M, Lamas GA, Packer M, Rouleau J, Roulea JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77
3. Miyazaki M, Sakonjo H, Takai S. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a highcholesterol diet. Br J Pharmacol 1999;128:523-9
4. Brasier AR, Recinos A 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002;22:1257-66
5. Feringa HHH, Bax JJ, Schouten O, Poldermans D. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Semin Cardiothorac Vasc Anesth 2006;10:25-31
6. Unger T, Azizi M, Belz GG. Blocking the tissue renin-angiotensin system: the future cornerstone of therapy. J Hum Hypertens 2000;14(Suppl 2):S23-31
7. Dendorfer A, Wolfrum S, Wellhoner P, Korsman K, Dominiak P. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br J Pharmacol 1997;122:1179-87
8. Lacourciere Y, Brunner H, Irwin R, Karlberg BE, Ramsay LE, Snavely DB, Dobbins TW, Faison EP, Nelson EB. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study group. J Hypertens 1994;12: 1387-93
9. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 1996;2:814-7
10. Packard KA, Wurdeman RL, Arouni AJ. ACE inhibitorinduced bronchial reactivity in patients with respiratory dysfunction. Ann Pharmacother 2002;36:1058-67
11. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001;92:26-30
12. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg 1999;89:1143-55
13. Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009;54:1778-84
14. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth 2010;57:736-44
15. Dyer M, Frieze A, Pittel B. The average performance of the greedy matching algorithm. Ann Appl Probab 1993;3:526-552
16. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensityscore matched samples. Stat Med 2009;28: 3083-107
17. Mascha E, Imrey P. Factor's affecting power of tests for multiple binary outcomes. Stat Med 2010;29:2890-904
18. Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis 2007;15:199-236
19. Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG, Kalkman CJ. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 2009;111:1217-26
20. Overlack A, Muller B, Schmidt L, Scheid ML, Muller M, Stumpe KO. Airway responsiveness and cough induced by angiotensin converting enzyme inhibition. J Hum Hypertens 1992;6:387-92
21. Overlack A. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Saf 1996;15:72-8
22. Sala H, Abad J, Juanmiquel L, Plans C, Ruiz J, Roig J, Morera J. Captopril and bronchial reactivity. Postgrad Med J 1986;62:76-7
23. Werner C, Poss J, Bohm M. Optimal antagonism of the renin-angiotensin- aldosterone system: do we need dual or triple therapy? Drugs 2010;70:1215-30
24. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Ostergren J, Probstfield J, Evaluation HIHop. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699-702
25. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302
26. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91
27. Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999;89:1388-92
28. Brabant SM, Eyraud D, Bertrand M, Coriat P. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists. Anesth Analg 1999;89:887-8
29. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995;80:473-9
30. Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008;22:180-6
31. Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005;100:636-44
32. Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu C-D, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH, IMAGINE Investigators. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31